Diagnosis of sarcoidosis

Current Opinion in Pulmonary Medicine

Volumn 14, Issue 5, 2008, Pages 455-461

  Costabel, Ulrich ^a,c   Ohshimo, Shinichiro ^a   Guzman, Josune ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHRLANDKLINIK   (Germany)

Author keywords

Cardiac magnetic resonance imaging; Diagnosis; L fgren's syndrome; Positron emission tomography; Transbronchial ultrasound guided needle aspiration

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FLUORODEOXYGLUCOSE F 18; GALLIUM; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; LYSOZYME; METIROSINE F 18; RADIOPHARMACEUTICAL AGENT; THALLIUM; UNCLASSIFIED DRUG; HLA DQ ANTIGEN; HLA DQB1 02 ANTIGEN; HLA-DRB1 ANTIGEN;

ACUTE DISEASE; ALLELE; BIOPSY TECHNIQUE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ENDOBRONCHIAL ULTRASONOGRAPHY; ENZYME BLOOD LEVEL; GENETIC ANALYSIS; GENETICS; HEREDITY; HUMAN; LOFGREN SYNDROME; LUNG FUNCTION TEST; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PULMONARY HYPERTENSION; RADIODIAGNOSIS; REMISSION; REVIEW; SARCOIDOSIS; SCINTIGRAPHY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TRACHEOBRONCHIAL TOILET; TRANSBRONCHIAL ASPIRATION; TRANSBRONCHIAL BIOPSY; VITAL CAPACITY; LUNG; PATHOLOGY;

BIOPSY, FINE-NEEDLE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; SARCOIDOSIS, PULMONARY;

EID: 53149128783     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283056a61     Document Type: Review

References (65)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160:736-755.
2. Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group: a case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:75-86.
3. Pietinalho A, Ohmichi M, Lofroos AB, et al. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan: a comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17:158-166.
4. Loddenkemper R, Kloppenborg A, Schoenfeld N, et al. Clinical findings in 715 patients with newly detected pulmonary sarcoidosis: results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft fur die Therapie von Lungenkrankheitan. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15:178-182.
5. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164:1885-1889.
6. Drent M, Wirnsberger RM, de Vries J, et al. Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J 1999; 13:718-722.
7. Grunewald J, Eklund A, OlerupO. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004; 169:696-702.
8. Judson MA, Baughman RP, Thompson BW, et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:204-211.
9. Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007; 132:207-213.
10. Scadding JG. Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years' observation. Br Med J 1961; 2:1165-1172.
11. Winterbauer RH, Belic N, Moores KD. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973; 78:65-71.
12. Reich JM, Brouns MC, O'Connor EA, Edwards MJ. Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest 1998; 113:147-153.
13. Sulica R, Teirstein AS, Kakarla S, et al. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest 2005; 128:1483-1489.
14. Kohn H, Klech H, Mostbeck A, Kummer F. 67Ga scanning for assessment of disease activity and therapy decisions in pulmonary sarcoidosis in comparison to chest radiography, serum ACE and blood T-lymphocytes. Eur J Nucl Med 1982; 7:413-416.
15. Nguyen BD. F-18 FDG PET imaging of disseminated sarcoidosis. Clin Nucl Med 2007; 32:53-54.
16. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006; 47:1571-1576.
17. Futamatsu H, Suzuki J, Adachi S, et al. Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia. Int J Cardiovasc Imaging 2006; 22:443-448.
18. Teirstein AS, Machac J, Almeida O, et al. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007; 132:1949-1953.
19. Kaira K, Oriuchi N, Otani Y, et al. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest 2007; 131:1019-1027.
20. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995; 119:167-172.
21. Ohira H, Tsujino I, Ishimaru S, et al. Myocardial imaging with (18)F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008; 35:933-941.
22. Schulte W, Kirsten D, Drent M, Costabel U. Cardiac involvement in sarcoidosis. Eur Respir Mon 2005; 32:130-149.
23. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 2005; 185:110-115.
24. Shigemitsu H, Nagai S, Sharma OP. Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Curr Opin Pulm Med 2007; 13:434-438.
25. Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamicsand prognosis. Thorax 2006; 61:68-74.
26. HandaT, Nagai S, Miki S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006; 129:1246-1252.
27. Baughman RP. Pulmonary hypertension associated with sarcoidosis. Arthritis Res Ther 2007; 9 (Suppl 2):S8-S14.
28. Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis: an approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980; 122:721-724.
29. Koonitz CH, Joyner LR, Nelson RA. Transbronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis. Ann Intern Med 1976; 85:64-66.
30. Garwood S, Judson MA, Silvestri G, et al. Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest 2007; 132:1298-1304.
31. Wong M, Yasufuku K, Nakajima T, et al. Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis. Eur Respir J 2007; 29:1182-1186.
32. Morales CF, Patefield AJ, Strollo PJ Jr, Schenk DA. Flexible transbronchial needle aspiration in the diagnosis of sarcoidosis. Chest 1994; 106:709-711.
33. Trisolini R, Lazzari Agli L, Cancellieri A, et al. Transbronchial needle aspiration improves the diagnostic yield of bronchoscopy in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21:147-151.
34. Annema JT, Rabe KF. State of the art lecture: EUS and EBUS in pulmonary medicine. Endoscopy 2006; 38 (Suppl 1):S118-S122.
35. Michael H, HoS, Pollack B, et al. Diagnosis of intra-abdominal and mediastinal sarcoidosis with EUS-guided FNA. Gastrointest Endosc 2008; 67:28-34.
36. Annema JT, Veselic M, Rabe KF. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of sarcoidosis. Eur Respir J 2005; 25:405-409.
37. Wildi SM, Judson MA, Fraig M, et al. Is endosonography guided fine needle aspiration (EUS-FNA) for sarcoidosis as good as we think? Thorax 2004; 59:794-799.
38. Fritscher-Ravens A, Sriram PV, TopalidisT, et al. Diagnosing sarcoidosis using endosonography-guided fine-needle aspiration. Chest 2000; 118:928-935.
39. Oki M, Saka H, Kitagawa C, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration is useful for diagnosing sarcoidosis. Respirology 2007; 12:863-868.
40. Smojver-JezekS, Peros-Golubicic T, Tekavec-Trkanjec J, et al. Transbronchial fine needle aspiration cytology in the diagnosis of mediastinal/hilar sarcoidosis. Cytopathology 2007; 18:3-7.
41. Gossot D, Toledo L, Fritsch S, Celerier M. Mediastinoscopy vs thoracoscopy for mediastinal biopsy. Results of a prospective nonrandomized study. Chest 1996; 110:1328-1331.
42. Porte H, Roumilhac D, Eraldi L, et al. The role of mediastinoscopy in the diagnosis of mediastinal lymphadenopathy. Eur J Cardiothorac Surg 1998; 13:196-199.
43. Mikhail JR, Shepherd M, Mitchell DN. Mediastinal lymph node biopsy in sarcoidosis. Endoscopy 1979; 11:5-8.
44. Hammoud ZT, Anderson RC, Meyers BF, et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg 1999; 118:894-899.
45. Costabel U, Guzman J, Drent M. Diagnostic approach to sarcoidosis. Eur Respir Mon 2005; 32:259-264.
46. Costabel U, Guzman J, Baughman RP. Systemic evaluation of a potential cutaneous sarcoidosis patient. Clin Dermatol 2007; 25:303-311.
47. Ozdemir OK, Celik G, Dalva K, et al. High CD95 expression of BAL lymphocytes predicts chronic course in patients with sarcoidosis. Respirology 2007; 12:869-873.
48. Heron M, Slieker WA, Zanen P, et al. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol 2008; 126:338-344.
49. Gronhagen-Riska C. Angiotensin-converting enzyme. I. Activity and correlation with serum lysozyme in sarcoidosis, other chest or lymph node diseases and healthy persons. Scand J Respir Dis 1979; 60:83-93.
50. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med 1975; 59:365-372.
51. Baughman R, Costabel U. Markers of sarcoidosis. In: Baughman R, editor. Sarcoidosis. New York: Taylor & Francis; 2006. pp. 435-462.
52. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
53. Biller H, Zissel G, Ruprecht B, et al. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur Respir J 2006; 28:1085-1090.
54. Kieszko R, Krawczyk P, Chocholska S, et al. Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis. Respir Med 2007; 101:645-654.
55. Kieszko R, Krawczyk P, Jankowska O, et al. The clinical significance of interleukin 18 assessment in sarcoidosis patients. Respir Med 2007; 101:722-728.
56. Hata M, Sugisaki K, Miyazaki E, et al. Circulating IL-12 p40 is increased in the patients with sarcoidosis, correlation with clinical markers. Intern Med 2007; 46:1387-1393.
57. Kruit A, Grutters JC, Ruven HJ, et al. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir Med 2007; 101:1563-1571.
58. Ashitani J, Matsumoto N, Nakazato M. Elevated alpha-defensin levels in plasma of patients with pulmonary sarcoidosis. Respirology 2007; 12:339-345.
59. Grunewald J, Eklund A. Sex-specific manifestations of Lofgren's syndrome. Am J Respir Crit Care Med 2007; 175:40-44.
60. Iannuzzi MC. Advances in the genetics of sarcoidosis. Proc Am Thorac Soc 2007; 4:457-460.
61. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37:357-364.
62. Rybicki BA, Walewski JL, MaliarikMJ, et al. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 2005; 77:491-499.
63. Spagnolo P, Sato H, Grutters JC, et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens 2007; 70:219-227.
64. Campo I, Morbini P, Zorzetto M, et al. Expression of receptor for advanced glycation end products in sarcoid granulomas. Am J Respir Crit Care Med 2007; 175:498-506.
65. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003; 361:1111-1118.